Different In Situ Immune Patterns between Primary Tumor and Lymph Node in Non-Small-Cell Lung Cancer: Potential Impact on Neoadjuvant Immunotherapy

BACKGROUND: Neoadjuvant immunotherapy is promising for locally advanced non-small-cell lung cancer (NSCLC). The in situ immune patterns, as a predictor of PD-1/PD-L1 blockade outcomes, of the primary tumor (PT) and metastatic lymph nodes (mLNs) are unknown. METHODS: Multiplex immunofluorescence stai...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Zheng-Hao, Long, Hao, Zhao, Ze-Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071859/
https://www.ncbi.nlm.nih.gov/pubmed/35528615
http://dx.doi.org/10.1155/2022/8513747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9071859/
https://www.ncbi.nlm.nih.gov/pubmed/35528615
http://dx.doi.org/10.1155/2022/8513747

Ejemplares similares